Chlamydia, Screening Practice Problem
State the practice problem in measurable terms and that reflect quality indicators. Include data that suggests a
- State the practice problem in measurable terms and that reflect quality indicators. Include data that suggests a practice problem exists. Do not use anecdotal experiences or opinions.
- Provide a purpose statement including the importance of improving patient outcomes.
- Analysis of the Existing Evidence (2 pages)
- Summarize the findings from the evidence analysis that support your practice problem. Include minimum of at least 5 evidence-based practice sources that support your practice problem. Identify research, clinical guidelines, expert opinions, and other relevant information. You must include two-three research studies in your analysis. Using your own words synthesize the evidence that supports your identified practice problem. There should be no quotes or personal opinions included in this section.
- Quality Improvement Process (1page)
- Describe the quality improvement process and the quality model that will be used. This is not your entire quality improvement plan, only a description of the quality improvement process and the quality model you chose. You will develop your specific quality improvement plan in week 4. Include a description of a quality improvement tool(s) that you will use in your quality improvement plan. (qualitative or quantitative analytic improvement tool)
- Explain why the specific process was selected and document your explanation with references.
I will attach some of evidence-based sources in the chat
Please use these 3 articles and the suggested articles can be substituted
Salomon, S. G., Torrone, E., Nakatsukasa-Ono, W., & Fine, D. N. (2017). Missed Opportunities for Chlamydia Screening in Title X Family Planning Clinics. Sexually Transmitted Diseases, 44(9), 519–523. https://doi.org/10.1097/OLQ.0000000000000641
Davidson, K. W., Barry, M. J., Mangione, C. M., Cabana, M., Caughey, A. B., Davis, E. M., Donahue, K. E., Doubeni, C. A., Krist, A. H., Kubik, M., Li, L., Ogedegbe, G., Pbert, L., Silverstein, M., Simon, M. A., Stevermer, J., Tseng, C.-W., & Wong, J. B. (2021). Screening for Chlamydia and Gonorrhea: US https://doi.org/10.1001/jama.2021.14081
Phillips, J. A. (2019). Chlamydia Infections. Workplace Health & Safety, 67(7), 375–376. https://doi.org/10.1177/2165079919853590
Territo, H., & Burstein, G. (2021). Chlamydia Screening Post COVID-19. Contemporary OB/GYN, 66(7), 1–4.
Freeman, J., Pettit, J., & Howe, C. (2020). Chlamydia test-of-cure in pregnancy. Canadian Family Physician Medecin de Famille Canadien, 66(6), 427–428.